What are the major opportunities in the Veterinary Autoimmune Disease Therapeutics market? What are the strategies for the Veterinary Autoimmune Disease Therapeutics market?

For detailed insights on the major opportunities and strategies in the Veterinary Autoimmune Disease Therapeutics market, Read More

How does the Veterinary Autoimmune Disease Therapeutics market relate to the overall economy and other similar markets?

For detailed insights on Veterinary Autoimmune Disease Therapeutics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Veterinary Autoimmune Disease Therapeutics market growth? SWOT analysis of the Veterinary Autoimmune Disease Therapeutics market.

For detailed insights on the key dynamics influencing the Veterinary Autoimmune Disease Therapeutics market growth and SWOT analysis of the Veterinary Autoimmune Disease Therapeutics industry, Read More

Veterinary Autoimmune Disease Therapeutics Market Report Infographic Image

Item added to cart!

Published : January 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Veterinary Autoimmune Disease Therapeutics Market Report 2026

Name: Veterinary Autoimmune Disease Therapeutics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Therapy Type (Corticosteroids, Azathioprine, Cyclosporine, Mycophenolate, Leflunomide, Cyclophosphamide), By Animal Type (Companion Animals, Livestock Animals, Other Animal Types), By Disease (Hypothyroidism, Pemphigus Disease, Canine Lupus, Auto-Immune Hemolytic Anemia, Bullous Pemphigoid, Discoid Lupus Erythematosus (DLE), Immune-Related Arthritis, Other Diseases), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Veterinary Autoimmune Disease Therapeutics Market Overview

• Veterinary Autoimmune Disease Therapeutics market size has reached to $3.46 billion in 2025

• Expected to grow to $4.61 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%

• Growth Driver: Increased Funding Propels Growth In Veterinary Research And Autoimmune Disease Treatments

• Market Trend: Biocytogen Launches RenBiologics to Advance Veterinary Autoimmune Disease Therapies with Fully Human Antibodies

• North America was the largest region in 2025.

What Is Covered Under Veterinary Autoimmune Disease Therapeutics Market?

Veterinary autoimmune disease therapeutics refer to treatments designed to manage and alleviate animal autoimmune diseases. These therapeutics aim to modulate or suppress the immune response to reduce inflammation, prevent further tissue damage, and improve the affected animal's overall health and quality of life. Veterinary autoimmune disease therapeutics are critical for managing these complex conditions and require a tailored approach based on the specific disease, the severity of the condition, and the individual animal's needs.

The main therapy types of veterinary autoimmune disease therapeutics are corticosteroids, azathioprine, cyclosporine, mycophenolate, leflunomide, cyclophosphamide, levothyroxine, folic acid, hydroxychloroquine, and chloroquine. Corticosteroids refer to a class of steroid hormones produced in the adrenal cortex. They are often used in medicine to reduce inflammation and suppress the immune system. For animals such as companion animals, livestock animals, and others with disease-type hypothyroidism, pemphigus disease, canine lupus, autoimmune Hemolytic anemia, bullous pemphigoid, discoid lupus erythematosus (DLE), immune-related arthritis, and others. It is distributed through veterinary hospitals and veterinary clinics.

Veterinary Autoimmune Disease Therapeutics market report bar graph

What Is The Veterinary Autoimmune Disease Therapeutics Market Size and Share 2026?

The veterinary autoimmune disease therapeutics market size has grown strongly in recent years. It will grow from $3.46 billion in 2025 to $3.69 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to limited treatment options for animal autoimmune diseases, high prevalence of hypothyroidism and pemphigus, reliance on corticosteroids as primary therapy, growing pet ownership, increasing veterinary consultations.

What Is The Veterinary Autoimmune Disease Therapeutics Market Growth Forecast?

The veterinary autoimmune disease therapeutics market size is expected to see strong growth in the next few years. It will grow to $4.61 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to advancements in immunomodulatory therapies, development of novel oral and injectable formulations, rising awareness of autoimmune conditions in companion animals, expansion of veterinary hospital and clinic networks, increasing adoption of precision medicine approaches. Major trends in the forecast period include rising use of corticosteroids and immunosuppressive therapies, increasing focus on companion animal autoimmune disease management, expansion of veterinary hospital and clinic networks, development of oral and injectable formulations for enhanced compliance, growing awareness of rare autoimmune diseases in animals.

Book your 30 minutes free consultation with our research experts

Global Veterinary Autoimmune Disease Therapeutics Market Segmentation

1) By Therapy Type: Corticosteroids, Azathioprine, Cyclosporine, Mycophenolate, Leflunomide, Cyclophosphamide

2) By Animal Type: Companion Animals, Livestock Animals, Other Animal Types

3) By Disease: Hypothyroidism, Pemphigus Disease, Canine Lupus, Auto-Immune Hemolytic Anemia, Bullous Pemphigoid, Discoid Lupus Erythematosus (DLE), Immune-Related Arthritis, Other Diseases

4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics

Subsegments:

1) By Corticosteroids: Prednisone, Prednisolone, Dexamethasone, Methylprednisolone, Triamcinolone

2) By Azathioprine: Azathioprine Oral Tablets, Azathioprine Injectable Formulation

3) By Cyclosporine: Oral Cyclosporine (Atopica), Injectable Cyclosporine

4) By Mycophenolate: Mycophenolate Mofetil (Oral Form), Mycophenolate Sodium (Injectable Form)

5) By Leflunomide: Leflunomide Tablets (Oral), Leflunomide Injection

6) By Cyclophosphamide: Oral Cyclophosphamide, Injectable Cyclophosphamide

What Is The Driver Of The Veterinary Autoimmune Disease Therapeutics Market?

The increasing funding for research in veterinary medicine is expected to propel the growth of the veterinary autoimmune disease therapeutics market going forward. Veterinary medicine is the branch of medicine that deals with the prevention, diagnosis, and treatment of diseases, disorders, and injuries in animals. The increased funding for research in veterinary medicine can be attributed to rising zoonotic diseases, the growing pet industry, advances in animal health technology, agricultural demands, and wildlife conservation efforts. Funding for research in veterinary autoimmune disease supports studies on disease mechanisms, diagnostic tools, and treatment options, enhancing veterinary medicine's ability to diagnose and manage these conditions effectively. For instance, in September 2025, according to the American Veterinary Medical Association (AVMA), a US-based not-for-profit association, the USDA Veterinary Service Grant Program $3.8 million in 2024, up to $15 million in subsequent years. Therefore, the increased funding for research in veterinary medicine is driving the growth of the veterinary autoimmune disease therapeutics industry.

Key Players In The Global Veterinary Autoimmune Disease Therapeutics Market

Major companies operating in the veterinary autoimmune disease therapeutics market are Pfizer Inc, Merck & Co Inc, AbbVie Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline, Takeda Pharmaceutical Company, Amgen Inc., Teva Pharmaceuticals Industries Ltd., Zoetis Inc, Boehringer Ingelheim International GmbH, Sumitomo Pharma Co. Ltd., IDEXX Laboratories Inc., Cipla Inc., Mallinckrodt Pharmaceuticals, Virbac S.A, Dechra Pharmaceuticals plc, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Heska Corporation, Bimeda Holdings PLC, Bayer Animal Health Inc, Aratana Therapeutics Inc, Hester Biosciences Limited

Global Veterinary Autoimmune Disease Therapeutics Market Trends and Insights

Major companies operating in the veterinary autoimmune disease therapeutics market are focusing on developing technologically advanced solutions. Such as RenBiologics to address several critical industry demands. RenBiologics develops innovative therapies for kidney-related conditions and chronic diseases, focusing on biologics and regenerative medicine to improve outcomes in areas like renal function and transplant success. For instance, in January 2024, according to the Biocytogen, a China-based biotechnology company, launched a new sub-brand, RenBiologics, to focus on the out-licensing of fully human antibodies for therapeutic development. This initiative aims to leverage Biocytogen's extensive library of over 400,000 fully human antibody sequences, generated through its proprietary RenMice platforms. RenBiologics will facilitate partnerships with pharmaceutical and biotechnology companies for the co-development and licensing of these antibodies, enhancing the potential for novel antibody-based therapeutics. The launch reflects Biocytogen's commitment to becoming a global resource in antibody discovery, with a vision to expedite the development of innovative treatments across various therapeutic areas.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Veterinary Autoimmune Disease Therapeutics Market?

In March 2024, AbbVie Inc., a US-based biopharmaceutical company that develops and sells medicines and solutions to address complex health issues, acquired Landos Biopharma for $137.5 million. With this acquisition, Abbvie aims to enhance its portfolio in inflammatory bowel diseases by advancing innovative therapies like NX-13, thereby addressing significant unmet needs in patient care. Landos Biopharma, Inc. is a US-based biopharmaceutical company that is advancing autoimmune therapies that could extend to treating similar conditions in animals.

Regional Outlook

North America was the largest region in the veterinary autoimmune disease therapeutics market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Veterinary Autoimmune Disease Therapeutics Market?

The veterinary autoimmune disease therapeutics market consists of revenues earned by entities by providing immunosuppressive medications, biologic therapies, supportive therapies and complementary therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary autoimmune disease therapeutics market also includes sales of prednisone, mycophenolate mofetil, and methotrexate. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Veterinary Autoimmune Disease Therapeutics Market Report 2026?

The veterinary autoimmune disease therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary autoimmune disease therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Veterinary Autoimmune Disease Therapeutics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$3.69 billion
Revenue Forecast In 2035	$4.61 billion
Growth Rate	CAGR of 6.6% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Therapy Type, Animal Type, Disease, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc, Merck & Co Inc, AbbVie Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline, Takeda Pharmaceutical Company, Amgen Inc., Teva Pharmaceuticals Industries Ltd., Zoetis Inc, Boehringer Ingelheim International GmbH, Sumitomo Pharma Co. Ltd., IDEXX Laboratories Inc., Cipla Inc., Mallinckrodt Pharmaceuticals, Virbac S.A, Dechra Pharmaceuticals plc, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Heska Corporation, Bimeda Holdings PLC, Bayer Animal Health Inc, Aratana Therapeutics Inc, Hester Biosciences Limited
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Veterinary Autoimmune Disease Therapeutics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Veterinary Autoimmune Disease Therapeutics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Veterinary Autoimmune Disease Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Veterinary Autoimmune Disease Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Use Of Corticosteroids And Immunosuppressive Therapies

4.2.2 Increasing Focus On Companion Animal Autoimmune Disease Management

4.2.3 Expansion Of Veterinary Hospital And Clinic Networks

4.2.4 Development Of Oral And Injectable Formulations For Enhanced Compliance

4.2.5 Growing Awareness Of Rare Autoimmune Diseases In Animals

5. Veterinary Autoimmune Disease Therapeutics Market Analysis Of End Use Industries

5.1 Veterinary Hospitals

5.2 Veterinary Clinics

5.3 Companion Animal Owners

5.4 Livestock Owners

5.5 Research Institutions

6. Veterinary Autoimmune Disease Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Veterinary Autoimmune Disease Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Veterinary Autoimmune Disease Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Veterinary Autoimmune Disease Therapeutics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Veterinary Autoimmune Disease Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Veterinary Autoimmune Disease Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Veterinary Autoimmune Disease Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Veterinary Autoimmune Disease Therapeutics Market Segmentation

9.1. Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Corticosteroids, Azathioprine, Cyclosporine, Mycophenolate, Leflunomide, Cyclophosphamide

9.2. Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Companion Animals, Livestock Animals, Other Animal Types

9.3. Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hypothyroidism, Pemphigus Disease, Canine Lupus, Auto-Immune Hemolytic Anemia, Bullous Pemphigoid, Discoid Lupus Erythematosus (DLE), Immune-Related Arthritis, Other Diseases

9.4. Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Veterinary Hospitals, Veterinary Clinics

9.5. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prednisone, Prednisolone, Dexamethasone, Methylprednisolone, Triamcinolone

9.6. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Azathioprine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Azathioprine Oral Tablets, Azathioprine Injectable Formulation

9.7. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Cyclosporine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Cyclosporine (Atopica), Injectable Cyclosporine

9.8. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Mycophenolate, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Mycophenolate Mofetil (Oral Form), Mycophenolate Sodium (Injectable Form)

9.9. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Leflunomide, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Leflunomide Tablets (Oral), Leflunomide Injection

9.10. Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Cyclophosphamide, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral Cyclophosphamide, Injectable Cyclophosphamide

10. Veterinary Autoimmune Disease Therapeutics Market Regional And Country Analysis

10.1. Global Veterinary Autoimmune Disease Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Veterinary Autoimmune Disease Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Veterinary Autoimmune Disease Therapeutics Market

11.1. Asia-Pacific Veterinary Autoimmune Disease Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Veterinary Autoimmune Disease Therapeutics Market

12.1. China Veterinary Autoimmune Disease Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Veterinary Autoimmune Disease Therapeutics Market

13.1. India Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Veterinary Autoimmune Disease Therapeutics Market

14.1. Japan Veterinary Autoimmune Disease Therapeutics Market Overview

14.2. Japan Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Veterinary Autoimmune Disease Therapeutics Market

15.1. Australia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Veterinary Autoimmune Disease Therapeutics Market

16.1. Indonesia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Veterinary Autoimmune Disease Therapeutics Market

17.1. South Korea Veterinary Autoimmune Disease Therapeutics Market Overview

17.2. South Korea Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Veterinary Autoimmune Disease Therapeutics Market

18.1. Taiwan Veterinary Autoimmune Disease Therapeutics Market Overview

18.2. Taiwan Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Veterinary Autoimmune Disease Therapeutics Market

19.1. South East Asia Veterinary Autoimmune Disease Therapeutics Market Overview

19.2. South East Asia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Veterinary Autoimmune Disease Therapeutics Market

20.1. Western Europe Veterinary Autoimmune Disease Therapeutics Market Overview

20.2. Western Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Veterinary Autoimmune Disease Therapeutics Market

21.1. UK Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Veterinary Autoimmune Disease Therapeutics Market

22.1. Germany Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Veterinary Autoimmune Disease Therapeutics Market

23.1. France Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Veterinary Autoimmune Disease Therapeutics Market

24.1. Italy Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Veterinary Autoimmune Disease Therapeutics Market

25.1. Spain Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Veterinary Autoimmune Disease Therapeutics Market

26.1. Eastern Europe Veterinary Autoimmune Disease Therapeutics Market Overview

26.2. Eastern Europe Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Veterinary Autoimmune Disease Therapeutics Market

27.1. Russia Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Veterinary Autoimmune Disease Therapeutics Market

28.1. North America Veterinary Autoimmune Disease Therapeutics Market Overview

28.2. North America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Veterinary Autoimmune Disease Therapeutics Market

29.1. USA Veterinary Autoimmune Disease Therapeutics Market Overview

29.2. USA Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Veterinary Autoimmune Disease Therapeutics Market

30.1. Canada Veterinary Autoimmune Disease Therapeutics Market Overview

30.2. Canada Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Veterinary Autoimmune Disease Therapeutics Market

31.1. South America Veterinary Autoimmune Disease Therapeutics Market Overview

31.2. South America Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Veterinary Autoimmune Disease Therapeutics Market

32.1. Brazil Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Veterinary Autoimmune Disease Therapeutics Market

33.1. Middle East Veterinary Autoimmune Disease Therapeutics Market Overview

33.2. Middle East Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Veterinary Autoimmune Disease Therapeutics Market

34.1. Africa Veterinary Autoimmune Disease Therapeutics Market Overview

34.2. Africa Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Segmentation By Animal Type, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Veterinary Autoimmune Disease Therapeutics Market Regulatory and Investment Landscape

36. Veterinary Autoimmune Disease Therapeutics Market Competitive Landscape And Company Profiles

36.1. Veterinary Autoimmune Disease Therapeutics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Veterinary Autoimmune Disease Therapeutics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Veterinary Autoimmune Disease Therapeutics Market Company Profiles

36.3.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Veterinary Autoimmune Disease Therapeutics Market Other Major And Innovative Companies

GlaxoSmithKline, Takeda Pharmaceutical Company, Amgen Inc., Teva Pharmaceuticals Industries Ltd., Zoetis Inc, Boehringer Ingelheim International GmbH, Sumitomo Pharma Co. Ltd., IDEXX Laboratories Inc., Cipla Inc., Mallinckrodt Pharmaceuticals, Virbac S.A, Dechra Pharmaceuticals plc, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited

38. Global Veterinary Autoimmune Disease Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Veterinary Autoimmune Disease Therapeutics Market

40. Veterinary Autoimmune Disease Therapeutics Market High Potential Countries, Segments and Strategies

40.1 Veterinary Autoimmune Disease Therapeutics Market In 2030 - Countries Offering Most New Opportunities

40.2 Veterinary Autoimmune Disease Therapeutics Market In 2030 - Segments Offering Most New Opportunities

40.3 Veterinary Autoimmune Disease Therapeutics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Veterinary Autoimmune Disease Therapeutics Market, Overview Of Key Products - Product Examples

Table 2: Global Veterinary Autoimmune Disease Therapeutics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Veterinary Autoimmune Disease Therapeutics Market, Supply Chain Analysis

Table 4: Global Veterinary Autoimmune Disease Therapeutics Market, Major Raw Material Providers

Table 5: Global Veterinary Autoimmune Disease Therapeutics Market, Major Resource Providers

Table 6: Global Veterinary Autoimmune Disease Therapeutics Market, Major Manufacturers (Suppliers)

Table 7: Global Veterinary Autoimmune Disease Therapeutics Market, Major Distributors And Channel Partners

Table 8: Global Veterinary Autoimmune Disease Therapeutics Market, Key Technologies & Future Trends

Table 9: Global Veterinary Autoimmune Disease Therapeutics Market, Major Trends

Table 10: Global Veterinary Autoimmune Disease Therapeutics Market, Major End Users

Table 11: Global Veterinary Autoimmune Disease Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Veterinary Autoimmune Disease Therapeutics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Veterinary Autoimmune Disease Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Veterinary Autoimmune Disease Therapeutics Market - TAM, US$ Billion, 2025

Table 15: Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Azathioprine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Cyclosporine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Mycophenolate, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Leflunomide, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Cyclophosphamide, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Veterinary Autoimmune Disease Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Global Veterinary Autoimmune Disease Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Asia-Pacific, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: China, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: India, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Japan, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Australia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Indonesia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South Korea, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Taiwan, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: South East Asia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Western Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: UK, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Germany, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: France, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Italy, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Spain, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Eastern Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: Russia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: North America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: USA, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Canada, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: South America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Brazil, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Middle East, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Africa, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 99: Global Veterinary Autoimmune Disease Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 100: Global Veterinary Autoimmune Disease Therapeutics Market - Company Scoring Matrix

Table 101: Pfizer Inc Financial Performance

Table 102: Merck & Co Inc Financial Performance

Table 103: AbbVie Inc. Financial Performance

Table 104: Sanofi S.A. Financial Performance

Table 105: Novartis AG Financial Performance

Table 106: Global Veterinary Autoimmune Disease Therapeutics Market, Competitive Benchmarking (In USD Billions)

Table 107: Global Veterinary Autoimmune Disease Therapeutics Market, Competitive Dashboard

Table 108: Global Veterinary Autoimmune Disease Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 109: Global, Veterinary Autoimmune Disease Therapeutics Market Size Gain ($ Billion), Segmentation By Therapy Type, 2025 – 2030

Table 110: Global, Veterinary Autoimmune Disease Therapeutics Market Size Gain ($ Billion), Segmentation By Animal Type, 2025 – 2030

Table 111: Global, Veterinary Autoimmune Disease Therapeutics Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030

List Of Figures

Figure 1: Global Veterinary Autoimmune Disease Therapeutics Market, Overview Of Key Products - Product Examples

Figure 2: Global Veterinary Autoimmune Disease Therapeutics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Veterinary Autoimmune Disease Therapeutics Market, Supply Chain Analysis

Figure 4: Global Veterinary Autoimmune Disease Therapeutics Market, Major Raw Material Providers

Figure 5: Global Veterinary Autoimmune Disease Therapeutics Market, Major Resource Providers

Figure 6: Global Veterinary Autoimmune Disease Therapeutics Market, Major Manufacturers (Suppliers)

Figure 7: Global Veterinary Autoimmune Disease Therapeutics Market, Major Distributors And Channel Partners

Figure 8: Global Veterinary Autoimmune Disease Therapeutics Market, Key Technologies & Future Trends

Figure 9: Global Veterinary Autoimmune Disease Therapeutics Market, Major Trends

Figure 10: Global Veterinary Autoimmune Disease Therapeutics Market, Major End Users

Figure 11: Global Veterinary Autoimmune Disease Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Veterinary Autoimmune Disease Therapeutics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Veterinary Autoimmune Disease Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Veterinary Autoimmune Disease Therapeutics Market - TAM, US$ Billion, 2025

Figure 15: Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Azathioprine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Cyclosporine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Mycophenolate, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Leflunomide, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Veterinary Autoimmune Disease Therapeutics Market, Sub-Segmentation Of Cyclophosphamide, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Veterinary Autoimmune Disease Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Global Veterinary Autoimmune Disease Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Asia-Pacific, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: China, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: India, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Japan, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Australia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Indonesia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South Korea, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Taiwan, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: South East Asia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Western Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: UK, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Germany, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: France, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Italy, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Spain, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Eastern Europe, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: Russia, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: North America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: USA, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Canada, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: South America, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Brazil, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Middle East, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Africa, Veterinary Autoimmune Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 99: Global Veterinary Autoimmune Disease Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 100: Global Veterinary Autoimmune Disease Therapeutics Market - Company Scoring Matrix

Figure 101: Pfizer Inc Financial Performance

Figure 102: Merck & Co Inc Financial Performance

Figure 103: AbbVie Inc. Financial Performance

Figure 104: Sanofi S.A. Financial Performance

Figure 105: Novartis AG Financial Performance

Figure 106: Global Veterinary Autoimmune Disease Therapeutics Market, Competitive Benchmarking (In USD Billions)

Figure 107: Global Veterinary Autoimmune Disease Therapeutics Market, Competitive Dashboard

Figure 108: Global Veterinary Autoimmune Disease Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 109: Global, Veterinary Autoimmune Disease Therapeutics Market Size Gain ($ Billion), Segmentation By Therapy Type, 2025 – 2030

Figure 110: Global, Veterinary Autoimmune Disease Therapeutics Market Size Gain ($ Billion), Segmentation By Animal Type, 2025 – 2030

Figure 111: Global, Veterinary Autoimmune Disease Therapeutics Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030

Industry Forecast: Canine Atopic Dermatitis Market to Generate $4.09 Billion Revenue by 2029

Veterinary Ophthalmology Equipment Market Revenue Outlook: Strategic Insights and Forecast to 2029

Emerging Trends Redefining the Pet Grooming Services Market Landscape: Pet Healthcare Market Embraces Technological Advancements With Digital Platform

Top Trends Driving Innovation and Change in the Porcine Vaccine Market: Strategic Partnerships In The Porcine Vaccine Market Pirbright And TVG Collaborate To Develop Innovative African Swine Fever Vaccines

Market Trends Influencing Strategic Decisions in the Poultry Vaccines Industry: Advancements In Poultry Vaccine Technology Through A Focus Genotype Evolution

Key Developments and Trends Steering the Veterinary Antibiotics Market Forward: Collaborative Strategies Transforming The Veterinary Antibiotics Market

Major Trends and Emerging Patterns in the Veterinary Disposables Market: Focus On Innovation In Veterinary Disposables Market

Key Factors Fueling the Growth of the Veterinary Imaging Equipment Market in 2025: Expanding Livestock Populations Fueling The Veterinary Imaging Equipment Market

Building Thermal Insulation Market Report 2026 - Global Outlook – By Material (Foamed Plastic, Mineral Wool, Aerogels, Cellulose, Other Materials ), By Product (Glass Wool, Mineral Wool, Expanded polystyrene (EPS), Extru...

Veterinary Vaccines Market Report 2026 - Global Outlook – By Vaccine Type (Live Attenuated, Inactivated (Killed), Recombinant Or Subunit, mRNA And DNA, Other Vaccine Types), By Animal Type (Canine, Feline, Equine, Bovine...

Drinking Places (Alcoholic Beverages) Market Report 2026 - Global Outlook – By Product (Beverages, Foods), By Application (Men, Women) – Market Size, Trends, Strategies, and Forecast to 2035...

Go Kart Market Report 2026 - Global Outlook – By Type (Electric, Gasoline, Other Types), By Seating Capacity (Single, Double Seater), By Age Group (Kids, Teens, Adults), By Application (Rental, Racing) – Market Size, Tre...

Companion Animal Veterinary Vaccines Market Report 2026 - Global Outlook – By Product (Inactivated, Live Attenuated, Recombinant, Other Products), By Route Of Administration (Oral, Parenteral, Other Routes Of Administrat...

Veterinary Antibiotics Market Report 2026 - Global Outlook – By Product (Anti-Parasitic, Anti-Bacterial, Non-Steroidal Anti-Inflammatory Drug, Other Products), By Administration (Premixes, Injections, Oral Powders, Oral ...

Frequently Asked Questions

What is the projected market size of the Veterinary Autoimmune Disease Therapeutics market by 2030?

The Veterinary Autoimmune Disease Therapeutics market was valued at $3.46 billion in 2025, increased to $3.46 billion in 2026, and is projected to reach $4.61 billion by 2030. request a sample here

What is the expected CAGR for the Veterinary Autoimmune Disease Therapeutics market during the forecast period 2025 - 2030?

The expected CAGR for the Veterinary Autoimmune Disease Therapeutics market during the forecast period 2025–2030 is 5.8%. request a sample here

What are the key factors driving the Veterinary Autoimmune Disease Therapeutics market?

Major growth driver of the market includes: The increasing funding for research in veterinary medicine is expected to propel the growth of the veterinary autoimmune disease therapeutics market going forward. Veterinary medicine is the branch of medicine that deals with the prevention, diagnosis, and treatment of diseases, disorders, and injuries in animals. The increased funding for research in veterinary medicine can be attributed to rising zoonotic diseases, the growing pet industry, advances in animal health technology, agricultural demands, and wildlife conservation efforts. Funding for research in veterinary autoimmune disease supports studies on disease mechanisms, diagnostic tools, and treatment options, enhancing veterinary medicine's ability to diagnose and manage these conditions effectively. For instance, in September 2025, according to the American Veterinary Medical Association (AVMA), a US-based not-for-profit association, the USDA Veterinary Service Grant Program $3.8 million in 2024, up to $15 million in subsequent years. Therefore, the increased funding for research in veterinary medicine is driving the growth of the veterinary autoimmune disease therapeutics market. in the Veterinary Autoimmune Disease Therapeutics market. For further insights on this market, request a sample here

Which end-use segment are covered in the Veterinary Autoimmune Disease Therapeutics market report?

The veterinary autoimmune disease therapeutics market covered in this report is segmented –
1) By Therapy Type: Corticosteroids, Azathioprine, Cyclosporine, Mycophenolate, Leflunomide, Cyclophosphamide
2) By Animal Type: Companion Animals, Livestock Animals, Other Animal Types
3) By Disease: Hypothyroidism, Pemphigus Disease, Canine Lupus, Auto-Immune Hemolytic Anemia, Bullous Pemphigoid, Discoid Lupus Erythematosus (DLE), Immune-Related Arthritis, Other Diseases
4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics Subsegments:
1) By Corticosteroids: Prednisone, Prednisolone, Dexamethasone, Methylprednisolone, Triamcinolone
2) By Azathioprine: Azathioprine Oral Tablets, Azathioprine Injectable Formulation
3) By Cyclosporine: Oral Cyclosporine (Atopica), Injectable Cyclosporine
4) By Mycophenolate: Mycophenolate Mofetil (Oral Form), Mycophenolate Sodium (Injectable Form)
5) By Leflunomide: Leflunomide Tablets (Oral), Leflunomide Injection
6) By Cyclophosphamide: Oral Cyclophosphamide, Injectable Cyclophosphamide request a sample here

What is the anticipated growth trend for the Veterinary Autoimmune Disease Therapeutics market?

Major trend in this market includes: Biocytogen Launches RenBiologics to Advance Veterinary Autoimmune Disease Therapies with Fully Human Antibodies For further insights on this market, request a sample here.

Who are the key players in the Veterinary Autoimmune Disease Therapeutics market?

Major companies operating in the Veterinary Autoimmune Disease Therapeutics market are Major companies operating in the veterinary autoimmune disease therapeutics market are Pfizer Inc, Merck & Co Inc, AbbVie Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline, Takeda Pharmaceutical Company, Amgen Inc., Teva Pharmaceuticals Industries Ltd., Zoetis Inc, Boehringer Ingelheim International GmbH, Sumitomo Pharma Co. Ltd., IDEXX Laboratories Inc., Cipla Inc., Mallinckrodt Pharmaceuticals, Virbac S.A, Dechra Pharmaceuticals plc, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Heska Corporation, Bimeda Holdings PLC, Bayer Animal Health Inc, Aratana Therapeutics Inc, Hester Biosciences Limited request a sample here.

Which region has the most growth potential in the Veterinary Autoimmune Disease Therapeutics market?

North America was the largest region in the veterinary autoimmune disease therapeutics market in 2025. The regions covered in the veterinary autoimmune disease therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.